Remy S. Petersen

Statistics

Publications

Citations

933

H-Index

Active since

2021

Affiliations

Amsterdam University Medical Centers(Current)

University of Amsterdam

Remy S. Petersen is an author at Amsterdam University Medical Centers specializing in hereditary angioedema, pharmacotherapy, and in vivo genome editing.

ORCID

Publications per year

2021–2024

Publications

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary Angioedema

Hilary Longhurst, Karen Lindsay, Remy S. Petersen et al. · New England Journal of Medicine · 2024 · 166 citations

Life Sciences, Genetics, Molecular Genetics +14

CRISPR-Based Therapy for Hereditary Angioedema

Danny M. Cohn, Padmalal Gurugama, Markus Magerl et al. · New England Journal of Medicine · 2024 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A phase 2 <scp>open‐label</scp> extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema

Remy S. Petersen, Laura Bordone, Marc A. Riedl et al. · Allergy · 2023 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +11

1–5 of 6